The present invention in general relates to a pharmaceutical dosage form comprising a multi layered release formulation formed by co extrusion. Said formulation in particular comprises a core layer comprising at least one polymer selected from polycaprolactone ethylcellulose or combinations thereof and a coat layer comprising at least one (co)polymer selected from the list comprising: polyethylene oxide polyethylene glycol Basic Butylated Methacrylate (co)polymer a (co)polymer of polyvinylcaprolactam PEG and polyvinylacetate or combinations thereof.
